跳至主要内容
临床试验/NCT00232674
NCT00232674已完成4 期

The Effect of Inhaled Corticosteroids on the Development of Emphysema in Smokers Assessed by Computed Tomography (CT).

AstraZeneca2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 1999年7月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
AstraZeneca
入组人数
240
试验地点
2
主要终点
The primary variable in the study was change in lung density measured by Computed Tomography annually.

研究概览

简要总结

To assess the effect of up to 4 years treatment with budesonide on progression of emphysema in patients with Chronic Obstructive Lung Disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical Chronic Obstructive Pulmonary Disease diagnosis

排除标准

  • No exacerbation within the last 30 days
  • no long term use of oral corticosteroids

结局指标

主要结局

The primary variable in the study was change in lung density measured by Computed Tomography annually.

次要结局

  • Decline in lung Function (FEV1) and exacerbation rate were measured biannually and decline in diffusion capacity (TLCO) annually.

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验